| 20/03/25 | 07:00:11 | 20 Mar 2025 | | Equity Fundraising to raise £3.0 million | RNS |
| 06/03/25 | 10:00:00 | 6 Mar 2025 | | Service agreement with Royal Marsden NHS Trust | RNS |
| 27/02/25 | 12:35:09 | 27 Feb 2025 | | Director dealing | RNS |
| 25/02/25 | 16:11:05 | 25 Feb 2025 | | Director dealing | RNS |
| 20/02/25 | 15:52:12 | 20 Feb 2025 | | Director dealing | RNS |
| 19/02/25 | 07:00:07 | 19 Feb 2025 | | Director dealing | RNS |
| 18/02/25 | 07:00:07 | 18 Feb 2025 | | Director dealing | RNS |
| 17/02/25 | 07:00:09 | 17 Feb 2025 | | EDX develops new ‘super test’ for prostate cancer | RNS |
| 14/02/25 | 07:00:07 | 14 Feb 2025 | | Appointment of director & deputy chair | RNS |
| 16/12/24 | 07:00:06 | 16 Dec 2024 | | Interim Report: Six Months to Sep 30, 2024 | RNS |
| 07/11/24 | 07:00:10 | 7 Nov 2024 | | Presentation to Aquis Showcase Event | RNS |
| 06/11/24 | 07:00:07 | 6 Nov 2024 | | New partnership to provide testicular cancer tests | RNS |
| 01/11/24 | 07:00:08 | 1 Nov 2024 | | Cancellation of warrants | RNS |
| 23/10/24 | 07:00:09 | 23 Oct 2024 | | Strategic investment via Placing of Shares | RNS |
| 30/09/24 | 15:40:19 | 30 Sept 2024 | | Annual General Meeting Results | RNS |
| 09/09/24 | 07:00:08 | 9 Sept 2024 | | Shareholder Update | RNS |
| 05/09/24 | 07:00:14 | 5 Sept 2024 | | Appointment of Chief Commercial Officer | RNS |
| 04/09/24 | 07:01:00 | 4 Sept 2024 | | Publication - Annual Report & Financial Statements | RNS |
| 04/09/24 | 07:00:12 | 4 Sept 2024 | | Posting of Notice of AGM and Annual Report | RNS |
| 02/09/24 | 07:00:10 | 2 Sept 2024 | | Distribution agreement with Caris Life Sciences | RNS |
| 23/08/24 | 07:00:08 | 23 Aug 2024 | | New 5-FU/Capecitabine Safety & Treatment Test | RNS |
| 12/07/24 | 11:24:43 | 12 Jul 2024 | | Investor Evening | RNS |
| 26/06/24 | 07:00:12 | 26 Jun 2024 | | Exclusive partnership for cancer assay | RNS |
| 20/06/24 | 07:00:09 | 20 Jun 2024 | | New development in cancer testing strategy | RNS |
| 24/04/24 | 11:33:04 | 24 Apr 2024 | | Admission to Apex segment of AQSE Growth Market | RNS |
| 01/03/24 | 07:00:12 | 1 Mar 2024 | | Appointment of Product Development Director | RNS |
| 28/02/24 | 07:01:00 | 28 Feb 2024 | | WRAP Retail Offer | RNS |
| 28/02/24 | 07:00:10 | 28 Feb 2024 | | Investment and Placing of Shares | RNS |
| 06/02/24 | 11:29:29 | 6 Feb 2024 | | Investment and Placing of New Shares | RNS |
| 15/01/24 | 07:00:05 | 15 Jan 2024 | | Director dealing | RNS |
| 08/01/24 | 07:00:04 | 8 Jan 2024 | | Shareholder Update | RNS |
| 05/01/24 | 09:31:07 | 5 Jan 2024 | | Director dealing - REPLACEMENT | RNS |
| 04/01/24 | 15:57:53 | 4 Jan 2024 | | Director dealing | RNS |
| 02/01/24 | 07:00:01 | 2 Jan 2024 | | Director dealing | RNS |
| 18/12/23 | 07:00:12 | 18 Dec 2023 | | Interim Report & Financial Statements | RNS |
| 21/11/23 | 07:00:12 | 21 Nov 2023 | | EDX Medical-Thermo Fisher Scientific collaboration | RNS |
| 25/10/23 | 15:00:00 | 25 Oct 2023 | | General Meeting results | RNS |
| 18/10/23 | 17:33:50 | 18 Oct 2023 | | Change of venue of General Meeting | RNS |
| 05/10/23 | 07:00:05 | 5 Oct 2023 | | Agreement to distribute cancer genomic tests | RNS |
| 02/10/23 | 15:15:01 | 2 Oct 2023 | | Posting of Notice of GM and Annual Report | RNS |
| 02/10/23 | 07:00:06 | 2 Oct 2023 | | Annual Report/Financial Statement to 31 March 2023 | RNS |
| 27/09/23 | 16:16:08 | 27 Sept 2023 | | Result of Annual General Meeting | RNS |
| 27/09/23 | 13:46:54 | 27 Sept 2023 | | Acquisition of Hutano Diagnostics Ltd | RNS |
| 04/09/23 | 07:00:04 | 4 Sept 2023 | | Posting of Notice of AGM | RNS |
| 12/07/23 | 07:00:06 | 12 Jul 2023 | | Commercial Director appointment | RNS |
| 30/06/23 | 07:00:12 | 30 Jun 2023 | | Strategic investment from Boru Ltd | RNS |
| 22/06/23 | 07:00:08 | 22 Jun 2023 | | EDX Medical Group PLC strengthens senior team | RNS |
| 19/06/23 | 07:00:04 | 19 Jun 2023 | | Appointment of Corporate Adviser and Broker | RNS |
